Prednisolone

Prednisolone

SCHEMBL765329

C[C@]12C=CC(=O)C=C1CCC1C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Prednisolone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 known ✓ P04150 10/20 1.00
HIF1A Q16665 9/20 1.00
HSD17B10 Q99714 8/20 1.00
PGR P06401 5/20 1.00
CYP3A4 P08684 4/20 1.00
CYP2C19 P33261 3/20 1.00
ABCB11 O95342 2/20 1.00
SERPINA6 P08185 2/20 1.00
NR3C2 P08235 2/20 1.00
TNF P01375 1/20 1.00
IL6 P05231 1/20 1.00
AR P10275 1/20 1.00
GLUL P15104 1/20 1.00
ADAM17 P78536 1/20 1.00
GPBAR1 Q8TDU6 1/20 1.00
ALDH1A1 P00352 2/20 0.70
ABCC4 O15439 1/20 0.70
NR1I2 O75469 1/20 0.70
PDE4D Q08499 1/20 0.70
LMNA P02545 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Prednisolone SCHEMBL12396679 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL14420691 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL2737385 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL6566835 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL4449434 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL11413677 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL23863778 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL13044469 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL2597917 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4
Prednisolone SCHEMBL29264693 1.00 NR3C1 (1.00) NR3C1HIF1AHSD17B10PGRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46190-E1 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-11-01 US disclosed
US-RE46190-E1 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-11-01 US disclosed
EP-2431403-B1 POLYMER CONJUGATE OF BIOACTIVE SUBSTANCE HAVING HYDROXY GROUP NIPPON KAYAKU KK (JP) 2016-09-28 EP disclosed
WO-2015063408-A2 METHOD FOR PREPARING STEROIDAL DERIVATIVES SANOFI (FR) 2015-05-07 WO disclosed
US-8808749-B2 Polymer conjugate of bioactive substance having hydroxy group NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-08-19 US disclosed
US-8808749-B2 Polymer conjugate of bioactive substance having hydroxy group NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-08-19 US disclosed
US-8703878-B2 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-04-22 US disclosed
US-8703878-B2 High-molecular weight conjugate of steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-04-22 US disclosed
US-20120116051-A1 Polymer Conjugate Of Bioactive Substance Having Hydroxy Group NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-10 US disclosed
US-20120116051-A1 Polymer Conjugate Of Bioactive Substance Having Hydroxy Group NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-10 US disclosed
EP-2431403-A1 POLYMER CONJUGATE OF BIOACTIVE SUBSTANCE HAVING HYDROXY GROUP Nippon Kayaku Kabushiki Kaisha (JP) 2012-03-21 EP disclosed
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292414-A1 High-Molecular Weight Conjugate Of Steroids CYP17A1, CYP21A2, HSD17B12 NR3C1 74/4885HIF1A 2922/4885HSD17B10 16/4885
US-20120116051-A1 Polymer Conjugate Of Bioactive Substance Having Hydroxy Group CTSL, CPA3, ADCY10 NR3C1 1956/4885HIF1A 887/4885HSD17B10 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.